Search Results - "Westley, Tracy"
-
1
Indirect treatment comparisons including network meta-analysis: Lenvatinib plus everolimus for the second-line treatment of advanced/metastatic renal cell carcinoma
Published in PloS one (05-03-2019)“…In the absence of clinical trials providing direct efficacy results, this study compares different methods of indirect treatment comparison (ITC), and their…”
Get full text
Journal Article -
2
Short-, Mid-, and Long-Term Efficacy of Deucravacitinib Versus Biologics and Nonbiologics for Plaque Psoriasis: A Network Meta-Analysis
Published in Dermatology and therapy (01-11-2023)“…Introduction Deucravacitinib, a newly approved oral medication for the treatment of patients with moderate to severe plaque psoriasis, demonstrated efficacy…”
Get full text
Journal Article -
3
Parental Neighborhood Safety Perceptions and Their Children's Health Behaviors: Associations by Child Age, Gender and Household Income
Published in Children, youth and environments (01-01-2013)“…This study examined relationships between parents' neighborhood safety perceptions (NSPs) and their children's physical activity, active commuting to school,…”
Get full text
Journal Article -
4
Neighborhood socioeconomic conditions and depression: a systematic review and meta-analysis
Published in Social Psychiatry and Psychiatric Epidemiology (01-11-2015)“…Purpose The evidence linking neighborhood socioeconomic conditions (NSEC) with depression is mixed. We performed a systematic review of this literature,…”
Get full text
Journal Article Book Review -
5
Tafasitamab Plus Lenalidomide Versus 3 Rituximab-Based Treatments for Non-Transplant Eligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Matching-Adjusted Indirect Comparison
Published in Advances in therapy (01-06-2022)“…Introduction Tafasitamab plus lenalidomide (TAFA + LEN) received accelerated US Food and Drug Administration approval and conditional European Medicines Agency…”
Get full text
Journal Article -
6
Simulated Treatment Comparison (STC) of Human Mesenchymal Stromal Cells (Remestemcel-L, REM) and Ruxolitinib (RUX) for Steroid-Refractory Acute Graft-Versus-Host Disease (SR aGVHD) Pediatric Patients
Published in Blood (13-11-2019)“…Introduction: Allo-HSCT was performed on 1771 US children in 2016. SR aGVHD is a life-threatening complication of allo-HSCT associated with substantial…”
Get full text
Journal Article -
7
Comparative Effectiveness of Combination Glasdegib+ Low-Dose Cytarabine (GLAS+LDAC) Vs Combination Venetoclax + Low-Dose Cytarabine (VEN+LDAC) Among Older Acute Myeloid Leukemia (AML) Patients Ineligible for Intensive Chemotherapy (NIC): Indirect Treatment Comparison (ITC) Methods
Published in Blood (29-11-2018)“…Older AML patients are often NIC and face poorer prognoses. Among less intensive AML treatments, GLAS+LDAC showed improved efficacy vs LDAC alone in a Phase II…”
Get full text
Journal Article -
8
Clinical Responses of Glasdegibplus Low-Dose Ara-C, Azacitidine, and Decitabine Among Acute Myeloid Leukemia (AML) Patients Ineligible to Receive Intensive Chemotherapy: Comparative Effectiveness Using Indirect Treatment Comparison (ITC) Methods
Published in Blood (29-11-2018)“…Currently there is no standard treatment option for AML patients not fit for intensive chemotherapy. Further clinical challenges include poorer prognosis…”
Get full text
Journal Article -
9
Clinical Efficacy and Patient Reported Impacts of Roflumilast Foam 0.3% in Seborrheic Dermatitis: An Analysis of STRATUM Data for Patients Unresponsive or Intolerant to Topical Corticosteroids
Published in Skin (Milwood, N.Y.) (18-03-2024)“…Objective. Roflumilast foam 0.3% has demonstrated efficacy and tolerability in a Phase 3 clinical trial of moderate-to-severe seborrheic dermatitis (SD)…”
Get full text
Journal Article -
10
Divergence from osteoporosis screening guidelines in older breast cancer patients treated with anti-estrogen therapy: A population-based cohort study
Published in Bone (New York, N.Y.) (01-11-2018)“…Older Breast Cancer (BC) survivors are an increased risk of osteoporosis due to natural aging and long-term cancer treatment-related toxicity. It is well known…”
Get full text
Journal Article -
11
Indirect comparison of deucravacitinib and other systemic treatments for moderate to severe plaque psoriasis in Asian populations: A systematic literature review and network meta‐analysis
Published in Journal of dermatology (11-11-2024)“…Expanding the systemic treatment options for patients with psoriasis, deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor is approved…”
Get full text
Journal Article -
12
-
13
A criterion-based approach to systematic and transparent comparative effectiveness: a case study in psoriatic arthritis
Published in Journal of comparative effectiveness research (01-11-2019)“…Indirect treatment comparisons are used when no direct comparison is available. Comparison networks should satisfy the transitivity assumption, that is, equal…”
Get full text
Journal Article -
14
Overall survival of glasdegib in combination with low-dose cytarabine, azacitidine, and decitabine among adult patients with previously untreated AML: comparative effectiveness using simulated treatment comparisons
Published in ClinicoEconomics and outcomes research (01-09-2019)“…Until recently, treatments for older patients with AML ineligible to receive intensive chemotherapies were limited to hypomethylating agents, low-dose…”
Get full text
Journal Article -
15
Patterns and predictors of emergency department visits among older patients after breast cancer surgery: A population-based cohort study
Published in Journal of geriatric oncology (01-05-2018)“…To characterize rates, reasons for, and associated predictors for emergency department (ED) visits after breast cancer (BC) surgery. All women over 65 years…”
Get full text
Journal Article -
16